Quest Diagnostics Incorporated (DGX)
Last Price$177.02.3%
Market Cap$19.6B
DGX Rating
DGX Quality rating performance
DGX Intrinsic Value
Key Highlights:
As of Mar 03, 2025 DGX Relative Value is $409.5, which is undervalued by 131.4%, compared to current share price of $177.0.
As of Mar 03, 2025 DGX DCF Value is $331.0, which is undervalued by 87.1%, compared to current share price of $177.0.
DGX Share Price History
1W 1.7%
1M 8.9%
6M 13.8%
YTD 29.0%
1Y 44.2%
3Y 38.6%
5Y 80.3%
10Y 205.6%
Share Price
Intrinsic Value
Drawdown
Total Return
vs SP500
vs NASDAQ
Crunching data... Almost there!
DGX Stock Metrics
Key stats
Income statement
Balance sheet
Cash Flow Statement
Valuation
Ratios
Per share
Per employee
Dividends & Yields
Base
$19.6B
$26.0B
$9,872.0M
$909.0M
Shares Outstanding
111M
Employees
N/A
Growth (CAGR)
5.0%
4.17%
17.25%
Profitability
32.4%
14.0%
13.5%
9.2%
103.3%
Intrinsic Value
$369.8 (109.0% undervalued)
$331.1
$408.5
$116.8
$162.2
83.5%
Return on Capital
Financial Health
$6,376.0M
7.0x
15.5x
102.2%
Dividends
9.1%
1.7%
36.4%
Jan 14, 2025
Earnings
Apr 21, 2025
BEAT by 2.3%
BEAT by 1.7%
10 Beat & null Miss
DGX Stock Financials
DGX Income Statement Metrics
Annual
Quarterly
LTM
DGX Cash Flow Statement Metrics
Annual
Quarterly
LTM
Operating Cash Flow (OCF)
$1,272.0M -26.0% YoY
Capital Expenditure (CAPEX)
($408.0M) +1.0% YoY
Free Cash Flow (FCF)
$864.0M -34.2% YoY
DGX Income Statement Overview
Annual
Quarterly
LTM
Dec'14
Dec'15
Dec'16
Dec'17
Dec'18
Dec'19
Dec'20
Dec'21
Dec'22
Dec'23
$9,252.0M (6.4%) YoY
Cost of revenue
$6,291.0M (2.5%) YoY
Pre-tax income
$1,130.0M (8.5%) YoY
12.2% margin
DGX Balance Sheet Overview
Annual
Quarterly
LTM
Dec'14
Dec'15
Dec'16
Dec'17
Dec'18
Dec'19
Dec'20
Dec'21
Dec'22
Dec'23
Assets
Liabilities
Total assets
$14.0B
Current assets ($2,372.0M, 16.9% of total)
$686.0M (4.9%)
$1,210.0M (8.6%)
Other current assets
$476.0M (3.4%)
Non-current assets ($11.7B, 83.1% of total)
$135.0M (1.0%)
$2,418.0M (17.2%)
$1,166.0M (8.3%)
Other non-current assets
$7,931.0M (56.6%)
Financial position
$4,683.0M
Cash & Short-term
Investments
Total Debt
DGX Stock Ratios
Annual
Quarterly
LTM
Industry Median
5Y Historical Average
Benchmark
DGX Earnings Surprises
Crunching data... Almost there!
DGX Dividends
DGX Dividend Yield
Crunching data... Almost there!
DGX Dividend Per Share
3Y
10Y
30Y
Annual
Quarterly
LTM
Competing with DGX
Overview
Ratings
Intrinsic Value
Valuation
Growth
Profitability
Health
Capital allocation
Momentum
Earnings
Dividends
Company name | Market Cap | Quality rating | Intrinsic value | 1Y Return | Revenue | Free Cash Flow | Revenue growth | FCF margin | Gross margin | ROIC | Total Debt to Equity |
$19.6B | 6.0 | $369.8 109.0% undervalued | 44.2% | $9,872.0M | $909.0M | 6.7% | 9.2% | 32.4% | 8.8% | 102.2% | |
$201.0B | 6.5 | $602.4 15.0% undervalued | (9.7%) | $42.9B | $7,267.0M | 0.1% | 16.9% | 41.5% | 8.3% | 63.1% | |
$151.3B | 6.1 | $167.0 18.8% overvalued | (19.4%) | $23.9B | $5,296.0M | (0.1%) | 22.2% | 59.5% | 5.9% | 32.3% | |
$36.5B | 7.4 | $103.7 17.9% overvalued | (11.0%) | $6,533.0M | $1,409.0M | (3.0%) | 21.6% | 65.9% | 14.7% | 55.8% | |
$36.1B | 7.2 | $219.3 49.8% overvalued | (23.5%) | $3,897.5M | $798.1M | 6.5% | 20.5% | 61.1% | 49.4% | 6.3% | |
$33.7B | 6.1 | $301.3 63.0% undervalued | (26.5%) | $15.4B | $2,114.0M | 2.5% | 13.7% | 31.4% | 8.8% | 21.7% | |
$27.1B | 7.0 | $869.6 31.5% overvalued | (1.4%) | $3,872.4M | $864.4M | 2.2% | 22.3% | 59.1% | 49.8% | (1,587.1%) | |
$22.2B | 6.5 | $236.1 36.5% overvalued | 7.2% | $2,958.4M | $619.6M | 0.1% | 20.9% | 58.2% | 19.4% | 0.0% | |
$21.2B | 6.1 | $621.0 144.4% undervalued | 17.1% | $13.0B | $1,095.9M | 0.8% | 8.4% | 26.9% | 6.0% | 24.1% | |
$18.5B | 6.0 | $70.9 50.4% overvalued | 58.6% | $1,532.0M | ($33.2M) | 54.9% | (2.2%) | 57.7% | (44.9%) | 54.2% | |
$13.9B | 6.2 | $147.2 74.8% undervalued | (37.1%) | $4,372.0M | $696.0M | (2.9%) | 15.9% | 65.4% | 34.6% | 93.8% |
FAQ
What is Quest Diagnostics Incorporated (DGX) stock rating?
As of today, Quest Diagnostics Incorporated has a stock rating of 6 (out of 10), which is considered Good.
is Quest Diagnostics Incorporated (DGX) a good stock to buy?
As of today, Quest Diagnostics Incorporated has a Good stock rating, which is 109.0% undervalued. According to Value Sense backtesting, stocks with similar profile tend to outperform the market by 3.2%.